儿童癫痫的长程管理

doi:10.12372/jcp.2023.22e0020

摘要/Abstract

摘要：

癫痫在儿童时期高发，严重影响了患儿及其家庭的生活质量。癫痫的治疗具有疗程长、影响因素多等特点，所以长程管理对于改善预后、提高生活质量至关重要。我国不同地区儿童癫痫的管理水平存在较大差距，需要进一步规范。文章就儿童癫痫的长程管理作一介绍。

Abstract:

The high incidence of epilepsy in children seriously affects the quality of life of children and their families. The treatment of epilepsy is characterized by long course of treatment and many influencing factors, so long-term management is very important for improving prognosis and quality of life. There is a big gap in the management level of children epilepsy in different areas of China, which needs to be further standardized. This article introduces the long-term management of epilepsy in children.

Key words: epilepsy, management, child

朱登纳, 牛国辉. 儿童癫痫的长程管理[J]. 临床儿科杂志, 2023, 41(3): 235-240.

ZHU Dengna, NIU Guohui. Long-term management of epilepsy in children[J]. Journal of Clinical Pediatrics, 2023, 41(3): 235-240.

参考文献 35

[1]	中华医学会儿科学分会神经学组. 儿童癫痫长程管理专家共识[J]. 中华儿科杂志, 2013, 51(9): 699-703.
[2]	Casetta I, Pugliatti M, Faggioli R, et al. Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996-2005[J]. Eur J Neurol, 2012, 19(2): 312-316. doi: 10.1111/j.1468-1331.2011.03506.x pmid: 21906212
[3]	Beghi E. The epidemiology of epilepsy[J]. Neuro-epidemiology, 2020, 54(2): 185-191.
[4]	Fleeman N, Bradley PM. Care delivery and self-management strategies for children with epilepsy[J]. Cochrane Database Syst Rev, 2018, 3: D6245.
[5]	Ferro MA, Avery L, Fayed N, et al. Child- and parent-reported quality of life trajectories in children with epilepsy: a prospective cohort study[J]. Epilepsia, 2017, 58(7): 1277-1286. doi: 10.1111/epi.13774 pmid: 28485850
[6]	Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study[J]. JAMA Neurol, 2018, 75(3): 279-286. doi: 10.1001/jamaneurol.2017.3949 pmid: 29279892
[7]	Hall-Flavin DK, Winner JG, Allen JD, et al. Using a pharmacogenomic algorithm to guide the treatment of depression[J]. Transl Psychiatry, 2012, 2: e172. doi: 10.1038/tp.2012.99
[8]	Gabr WM, Shams ME. Adherence to medication among outpatient adolescents with epilepsy[J]. Saudi Pharm J, 2015, 23(1): 33-40. doi: 10.1016/j.jsps.2014.05.003 pmid: 25685041
[9]	O' Rourke G, O' Brien JJ. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy[J]. Seizure, 2017, 45: 160-168. doi: S1059-1311(16)30321-1 pmid: 28063375
[10]	von Gaudecker JR, Buelow JM, Miller WR, et al. Social determinants of health associated with epilepsy treatment adherence in the United States: a scoping review[J]. Epilepsy Behav, 2021, 124: 108328. doi: 10.1016/j.yebeh.2021.108328
[11]	中国抗癫痫协会精准医学与药物不良反应监测专业委员会. 抗癫痫药物所致不良反应的研究进展[J]. 癫痫杂志, 2019, 5(4): 280-284.
[12]	Kaushik S, Chopra D, Sharma S, et al. Adverse drug reactions of anti-epileptic drugs in children with epilepsy: a cross-sectional study[J]. Curr Drug Saf, 2019, 14(3): 217-224. doi: 10.2174/1574886314666190311112710 pmid: 30854975
[13]	Shi YW, Min FL, Zhou D, et al. HLA-A*24: 02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions[J]. Neurology, 2017, 88(23): 2183-2191. doi: 10.1212/WNL.0000000000004008
[14]	Lamberink HJ, Otte WM, Geleijns K, et al. Antiepileptic drug withdrawal in medically and surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its predictors[J]. Epileptic Disord, 2015, 17(3): 211-228. doi: 10.1684/epd.2015.0764 pmid: 26292909
[15]	齐自娟, 黎振声, 董李, 等. 抗癫痫药物减停及停药后癫痫复发风险的研究进展[J]. 解放军医学院学报, 2021, 42(9): 983-987.
[16]	Campistol J. Epilepsy in inborn errors of metabolism with therapeutic options[J]. Semin Pediatr Neurol, 2016, 23(4): 321-331. doi: S1071-9091(16)30036-5 pmid: 28284393
[17]	van Karnebeek C, Sayson B, Lee J, et al. Metabolic evaluation of epilepsy: a diagnostic algorithm with focus on treatable conditions[J]. Front Neurol, 2018, 9: 1016. doi: 10.3389/fneur.2018.01016 pmid: 30559706
[18]	Rheims S, Auvin S. Attention deficit/hyperactivity disorder and epilepsy[J]. Curr Opin Neurol, 2021, 34(2): 219-225. doi: 10.1097/WCO.0000000000000903 pmid: 33464761
[19]	Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults[J]. Med J Aust, 2018, 208(5): 226-233. pmid: 29540143
[20]	中华儿科杂志编辑委员会, 中华医学会儿科学分会, 神经学组中国抗癫痫协会. 生酮饮食疗法在癫痫及相关神经系统疾病中的应用专家共识[J]. 中华儿科杂志, 2019, 57(11): 820-825.
[21]	Sondhi V, Agarwala A, Pandey RM, et al. Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial[J]. JAMA Pediatr, 2020, 174(10): 944-951. doi: 10.1001/jamapediatrics.2020.2282
[22]	Singh SP, Sankaraneni R, Antony AR. Evidence-based guidelines for the management of epilepsy[J]. Neurol India, 2017, 65(Supple): S6-S11.
[23]	Orosz I, McCormick D, Zamponi N, et al. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children[J]. Epilepsia, 2014, 55(10): 1576-1584. doi: 10.1111/epi.12762 pmid: 25231724
[24]	中国抗癫痫协会神经调控专业委员会, 中国医师协会神经调控专业委员会, 中华医学会神经外科分会神经生理学组. 迷走神经刺激治疗药物难治性癫痫的中国专家共识[J]. 癫痫杂志, 2021, 7(3): 191-196.
[25]	Starnes K, Miller K, Wong-Kisiel L, et al. A review of neurostimulation for epilepsy in pediatrics[J]. Brain Sci, 2019, 9(10): 283. doi: 10.3390/brainsci9100283
[26]	Mortazavi A, Elliott RS, Phan TN, et al. Responsive neurostimulation for the treatment of medically refractory epilepsy in pediatric patients: strategies, outcomes, and technical considerations[J]. J Neurosurg Pediatr, 2021: 1-8.
[27]	Aaberg KM, Bakken IJ, Lossius MI, et al. Comorbidity and childhood epilepsy: a nationwide registry study[J]. Pediatrics, 2016, 138(3): e20160921. doi: 10.1542/peds.2016-0921
[28]	Park KJ, Kim MJ, Yum MS, et al. Clinical and neuropsychological characteristics of children with epilepsy and attention-deficit/hyperactivity disorder[J]. Seizure, 2021, 91: 325-331. doi: 10.1016/j.seizure.2021.06.022 pmid: 34274892
[29]	Lukmanji S, Manji SA, Kadhim S, et al. The co-occurrence of epilepsy and autism: a systematic review[J]. Epilepsy Behav, 2019, 98(Pt A): 238-248. doi: S1525-5050(19)30494-9 pmid: 31398688
[30]	Nobili L, Beniczky S, Eriksson SH, et al. Expert opinion: managing sleep disturbances in people with epilepsy[J]. Epilepsy Behav, 2021, 124: 108341. doi: 10.1016/j.yebeh.2021.108341
[31]	邵晓丽, 胡佳妮, 姚银萍, 等. 遗传性癫痫伴热性惊厥附加症患儿的疫苗接种风险分析[J]. 中华神经医学杂志, 2020, 19(2): 176-180.
[32]	杭州市疾病预防控制中心, 苏州市疾病预防控制中心, 上海市疾病预防控制中心, 等. 特殊健康状态儿童预防接种专家共识之八—癫痫与预防接种[J]. 中国实用儿科杂志, 2019, 34(2): 82-84.
[33]	刘家琪, 杨逸昊, 王胜, 等. 新型冠状病毒疫苗与癫痫相关研究进展[J]. 癫痫杂志, 2021, 7(4): 327-334.
[34]	徐保平, 魏庄, 卢根, 等. 儿童新型冠状病毒疫苗预防接种20问[J]. 中华实用儿科临床杂志, 2021, 36(18): 1368-1372.
[35]	尹延肖, 余年, 狄晴. 癫痫发作诱因的研究现状[J]. 癫痫杂志, 2017, 3(4): 310 -314.